Kazuyoshi Kubo
Miyazaki, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
High incidence of serious infections requiring hospitalisation in human T-cell leukaemia virus type 1-positive rheumatoid arthritis: A case-controlled observational study.
Journal: Modern rheumatology
Published: June 23, 2021
Human T-cell leukemia virus type 1 may invalidate T-SPOT.TB assay results in rheumatoid arthritis patients: A retrospective case-control observational study.
Journal: PloS one
Published: March 09, 2020
The time-sequential changes of risk factors for adult T-cell leukemia development in human T-cell leukemia virus-positive patients with rheumatoid arthritis: a retrospective cohort study.
Journal: Modern rheumatology
Published: September 25, 2018
Leukocytapheresis in rheumatoid arthritis.
Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
Published: September 19, 2017
Evaluation of Line Immunoassay to Detect HTLV-1 Infection in an Endemic Area, Southwestern Japan; Comparison with Polymerase Chain Reaction and Western Blot.
Journal: Clinical laboratory
Published: February 10, 2017
Possible Case of Novel Spotted Fever Group Rickettsiosis in Traveler Returning to Japan from India.
Journal: Emerging infectious diseases
Published: May 19, 2016
Severe fever with thrombocytopenia syndrome with myocardial dysfunction and encephalopathy: A case report.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: November 17, 2015
Crystalglobulinemia with fulminant course with cylinder-like bodies on peripheral blood smear.
Journal: Internal medicine (Tokyo, Japan)
Published: August 19, 2014
Use of anti-tumor necrosis factor biologics in the treatment of rheumatoid arthritis does not change human T-lymphotropic virus type 1 markers: a case series.
Journal: Modern rheumatology
Published: November 21, 2013
Treatment with anti–tumor necrosis factor biologic agents in human T lymphotropic virus type I–positive patients with rheumatoid arthritis.
Journal: Arthritis care & research
Published: April 03, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026